Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Multiple Myeloma 4Barrett Esophagus 3Venous Thromboembolism 2Tobacco Use Disorder 2Prostatic Neoplasms 2Precancerous Conditions 2Polycythemia Vera 2Myocardial Infarction 2Esophageal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Vascular Diseases 1Triple Negative Breast Neoplasms 1Thromboembolism 1Thrombocytopenia 1Thrombocythemia, Essential 1Stroke 1Soft Tissue Neoplasms 1Smoking Cessation 1Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm, Residual 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Pulmonary Nodules 1

Interventions

Alpelisib 4berzosertib 3Fulvestrant 3Everolimus 3parsaclisib 2Topotecan 2NVP-BKM120 2Cetuximab 2talazoparib 1sotorasib 1serabelisib 1ruxolitinib 1duvelisib 1dapagliflozin 1cobimetinib 1ceralasertib 1binimetinib 1avelumab 1Vemurafenib 1SF 1126 1Rituximab 1Paclitaxel 1Oxaliplatin 1Leuprolide 1Leucovorin 1Letrozole 1Irinotecan 1Goserelin 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hereditary Sensory and Autonomic Neuropathies × Aspirin × Clear all
NCT02467582 2025-05-16

Adjuvant Aspirin Treatment for Colon Cancer Patients

Swiss Cancer Institute

Phase 3 Terminated
1,040 enrolled 11 charts
Gastrointestinal

Colonic Neoplasms, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡